RAP 0.00% 20.5¢ resapp health limited

2020 commercialisation, page-614

  1. 1,544 Posts.
    lightbulb Created with Sketch. 429
    The following NHSx webinar gives an insight into the assessment process for new tech - the key looks to be evidenced base studies and results! No surprise RAP is exploring these studies with the German hospitals! This kind of assessment would fundamentally form the basis for all other countries too.


 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.